CADL•benzinga•
Candel Therapeutics Announces Oral Presentation Of Phase 3 CAN-2409 Results In Localized Prostate Cancer At ASCO 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 23, 2025 by benzinga